- Home
- NEO vs PTA Comparison
NEO vs PTA Comparison
Compare NEO & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- PTA
- Stock Information
- Founded
- NEO 2001
- PTA 2020
- Country
- NEO United States
- PTA United States
- Employees
- NEO N/A
- PTA N/A
- Industry
- NEO Precision Instruments
- PTA Trusts Except Educational Religious and Charitable
- Sector
- NEO Health Care
- PTA Finance
- Exchange
- NEO Nasdaq
- PTA Nasdaq
- Market Cap
- NEO 1.2B
- PTA 1.0B
- IPO Year
- NEO 1999
- PTA N/A
- Fundamental
- Price
- NEO $8.04
- PTA $19.24
- Analyst Decision
- NEO Buy
- PTA
- Analyst Count
- NEO 9
- PTA 0
- Target Price
- NEO $13.31
- PTA N/A
- AVG Volume (30 Days)
- NEO 3.1M
- PTA 159.2K
- Earning Date
- NEO 04-29-2025
- PTA 01-01-0001
- Dividend Yield
- NEO N/A
- PTA 8.31%
- EPS Growth
- NEO N/A
- PTA N/A
- EPS
- NEO N/A
- PTA N/A
- Revenue
- NEO $672,361,000.00
- PTA N/A
- Revenue This Year
- NEO $13.05
- PTA N/A
- Revenue Next Year
- NEO $11.18
- PTA N/A
- P/E Ratio
- NEO N/A
- PTA N/A
- Revenue Growth
- NEO 10.10
- PTA N/A
- 52 Week Low
- NEO $6.08
- PTA $15.84
- 52 Week High
- NEO $19.11
- PTA $19.67
- Technical
- Relative Strength Index (RSI)
- NEO 43.86
- PTA 60.53
- Support Level
- NEO $7.66
- PTA $18.86
- Resistance Level
- NEO $8.31
- PTA $19.24
- Average True Range (ATR)
- NEO 0.76
- PTA 0.23
- MACD
- NEO -0.01
- PTA 0.11
- Stochastic Oscillator
- NEO 45.94
- PTA 100.00
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.